Name | CCG-273220 |
---|
Description | CCG-273220 is a covalent inhibitor of G protein-coupled receptor (GPCR) kinase 5 (GRK5) with an IC50 value of 220 nM. CCG-273220 is highly selective to GRK5 over GRK2 (IC50=350 μM) by binding Cys474, a GRK5 subfamily-specific residue, as a covalent handle[1]. |
---|---|
Related Catalog | |
Target |
IC50: 220 nM (GRK5)[1] |
In Vitro | Human GRKs (GRK1−GRK7) are classified into three subfamilies: GRK1 (GRK1 and GRK7), GRK2 (GRK2 and GRK3), and GRK4 (GRK4, GRK5, and GRK6)[1]. CCG-273220 (compound 9e) shows moderate potency (GRK5 IC50=220 nM) but 1500-fold selectivity over GRK2 (IC50=350 μM)[1]. |
References |
Molecular Formula | C26H24ClFN4O3 |
---|---|
Molecular Weight | 494.95 |